Results 191 to 200 of about 15,426 (247)

Refractory phenotype of Aspergillus-sensitized asthma with bronchiectasis and allergic bronchopulmonary aspergillosis. [PDF]

J Allergy Clin Immunol Glob
Nomura N, Matsumoto H, Asano K, Hayashi Y, Yokoyama A, Nishimura Y, Hashimoto N, Sakagami T, Fukunaga K, Hizawa N, Yamasaki A, Nagase H, Hattori N, Kondo M, Harada N, Sugiura H, Miki M, Kimura T, Toyoshima M, Matsuno O, Koh H, Kita T, Tomioka H, Tomii K, Ohnishi H, Takata S, Tobino K, Imokawa S, Sunadome H, Nagasaki T, Oguma T, Tanabe N, Hirai T, BEXAS study.   +33 more
europepmc   +1 more source

Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis. [PDF]

J Allergy Clin Immunol Glob
Lamothe PA, Pruett CLH, Smirnova N, Shepherd A, Runnstrom MC, Park J, Zhang RH, Zhao L, Swenson C, Lee FE.   +9 more
europepmc   +1 more source

Allergic bronchopulmonary aspergillosis with metachronous isolation of three distinct Aspergillus species. [PDF]

Respirol Case Rep
Sasahara Y, Akata K, Yamasaki K, Orihashi T, Yatera K.   +4 more
europepmc   +1 more source

Case Report: Allergic Bronchopulmonary Aspergillosis and Tropical Pulmonary Eosinophilia Co-Occurrence Masquerading as Refractory Allergic Bronchopulmonary Aspergillosis. [PDF]

Am J Trop Med Hyg
Singh M, Peter DK, Gupta S, Rani V V, Singh S.   +4 more
europepmc   +1 more source

Clinical Relevance of Elevated Serum Carcinoembryonic Antigen in Allergic Bronchopulmonary Aspergillosis/Mycosis: A Multicenter Retrospective Study. [PDF]

J Asthma Allergy
Ge H, Cai R, Chen X, Liu B, Hu X, Deng S, Li H, Dai L, Tang J, Tang H, Gong X, Wu C, Wang G, Li G, Liu B, Wang J, Tang Y, Li X, Feng J.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in adults with bronchial asthma: a systematic review of global data.

Journal of Allergy and Clinical Immunology: in Practice, 2023
BACKGROUND The prevalence of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patients remains unclear and is likely different across geographic locales.
R. Agarwal, V. Muthu, I. Sehgal, S. Dhooria, K. Prasad, Kathirvel Soundappan, S. Rudramurthy, A. Aggarwal, A. Chakrabarti   +8 more
semanticscholar   +3 more sources

Allergic Bronchopulmonary Aspergillosis.

Clinics in Chest Medicine, 2022
Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic disorder caused by immune reactions against Aspergillus fumigatus. ABPA most commonly complicates the course of patients with poorly controlled asthma. Patients commonly present with uncontrolled asthma, fleeting pulmonary opacities, and bronchiectasis.
R. Agarwal, V. Muthu, I. Sehgal, S. Dhooria, K. Prasad, A. Aggarwal   +5 more
semanticscholar   +4 more sources

Allergic Bronchopulmonary Aspergillosis

Chest, 2009
Allergic bronchopulmonary aspergillosis (ABPA) is an immunologic pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus. Clinically, a patient presents with chronic asthma, recurrent pulmonary infiltrates, and bronchiectasis. The population prevalence of ABPA is not clearly known, but the prevalence in asthma clinics is reported to be ...
Viswanath P. Kurup, Alan P. Knutsen
exaly   +5 more sources

Diagnostic cut-offs and clinical utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis.

Journal of Allergy and Clinical Immunology: in Practice, 2020
BACKGROUND The clinical utility of IgE against recombinant Aspergillus fumigatus-specific (rAsp) antigens in allergic bronchopulmonary aspergillosis (ABPA) remains unclear.
V. Muthu, P. Singh, Hansraj Choudhary, I. Sehgal, S. Dhooria, K. Prasad, A. Aggarwal, M. Garg, A. Chakrabarti, R. Agarwal   +9 more
semanticscholar   +3 more sources